Platelet (PLT) alloantigens are responsible for the pathogenesis of neonatal alloimmune thrombocytopenia (NAIT). Preventive, therapeutic and diagnostic advances are needed so that this self-limited disorder does not cause in utero or postnatal bleeding complications. In order to develop comprehensive screening and prevention programs, identification of the populations at risk is needed. The first goal of our proposal is to study the immunogenetics of the PLT-specific alloantigen systems in a variety of ethnic/racial groups. Improved methods of diagnosis, antenatal evaluation and elucidation of the immunologic factors that contribute to the pathogenesis of NAIT are needed. The second goal of this proposal is to characterize the clinical relevance of the alloantigens and antiplatelet antibodies involved in NAIT, including immunoglobulin subclass and allotype, cytotoxic mechanisms and target antigens. We will use our established PLT immunologic assays and in vitro cytotoxic assays to study PLT antibodies collected prospectively from babies with immune thrombocytopenia and from a serum bank of our previous patients. Development of a cDNA library will be used to detect and identify new PLT alloantigen systems. Production of recombinant PLT alloantigen mimics will be used to characterize PLT alloantibodies and to develop simplified methods of diagnosis. Estimation of fetal/newborn PLT turnover will be done by measurement of fetal glycocalicin levels in plasma and amniotic fluid. These studies should provide immunogenetic and immunologic information that will be of therapeutic and preventative relevance.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL049748-02
Application #
3368760
Study Section
Special Emphasis Panel (ZHL1 (01))
Project Start
1992-09-30
Project End
1996-08-31
Budget Start
1993-09-30
Budget End
1994-08-31
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Liu, L X; Nardi, M A; Casella, J F et al. (1996) Inhibition of binding of anti-PLA1 antibodies to platelets with monoclonal antibody LK-4. Evidence for multiple PLA1 receptor sites on platelet GPIIIa. Blood 88:3601-7
Kim, H O; Jin, Y; Kickler, T S et al. (1995) Gene frequencies of the five major human platelet antigens in African American, white, and Korean populations. Transfusion 35:863-7
Weiss, E J; Goldschmidt-Clermont, P J; Grigoryev, D et al. (1995) A monoclonal antibody (SZ21) specific for platelet GPIIIa distinguishes P1A1 from P1A2. Tissue Antigens 46:374-81
Kim, H O; Kennedy, S D; Kickler, T S (1995) Studies using immobilized platelet glycoproteins for detection of platelet alloantibodies. Am J Clin Pathol 104:258-63
Khouzami, A N; Kickler, T S; Bray, P F et al. (1995) Molecular genotyping of fetal platelet antigens with uncultured amniocytes. Am J Obstet Gynecol 173:1202-6
Bray, P F; Jin, Y; Kickler, T (1994) Rapid genotyping of the five major platelet alloantigens by reverse dot-blot hybridization. Blood 84:4361-7
Barron-Casella, E A; Kickler, T S; Rogers, O C et al. (1994) Expression and purification of functional recombinant epitopes for the platelet antigens, PlA1 and PlA2. Blood 84:1157-63
Zinkham, W H; Seidler, A J; Kickler, T S (1994) Variable degrees of suppression of hemoglobin S synthesis in subjects with hemoglobin SS disease on a long-term transfusion regimen. J Pediatr 124:215-9
Robinson, T M; Kickler, T S; Walker, L K et al. (1993) Effect of extracorporeal membrane oxygenation on platelets in newborns. Crit Care Med 21:1029-34